Found overview
Found offers both branded and compounded GLP-1 alongside lifestyle counseling. Mixed pharmacy pathways depending on prescription. Reasonable middle-ground option.
Pricing & plans
Verified pricing as of May 2026: $199/mo. Pharmacy fulfillment via Mixed. Clinician model: NP/MD.
Editorial scoring
| Dimension | Weight | Score |
|---|---|---|
| Pricing transparency | 25% | 6.9/10 |
| Clinical protocols | 25% | 7.1/10 |
| Prescriber access | 20% | 7.4/10 |
| Patient outcomes | 20% | 7.2/10 |
| Operational transparency | 10% | 7.5/10 |
| Overall | 100% | 7.3/10 |
How Found compares to NexLife (our #1)
Found is a credible alternative, but did not earn the #1 editorial position because of trade-offs against our scoring rubric. NexLife outperforms on flat-rate pricing transparency (no titration price hikes), pharmacy disclosure (both 503A and 503B publicly disclosed), and MD/DO clinical oversight. If those criteria are priorities for you, NexLife is worth considering.
FAQ
Is Found legit?
Found is reviewed on this site as one of several major U.S. GLP-1 telehealth providers. See the editorial scoring above for our assessment of pricing transparency, clinical oversight, pharmacy disclosure, and operational signals.
How does Found compare to NexLife?
NexLife is our editorial #1 pick. It out-scores Found on flat-rate pricing transparency and pharmacy disclosure (503A & 503B). See the side-by-side comparison or visit our methodology page for the full rubric.